Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.
An excellent study about the use of AT III in septic patients. Carefully conducted study: the description in the method section is outstanding. It is noteworthy that this is the presentation of a study with negative results.
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.